Microbix Biosystems Inc. (MBX.TO)

0.4900 +0.0050 (+1.03%) At close: 03:35PM EDT

Microbix Biosystems Inc.

265 Watline Avenue
Mississauga, ON L4Z 1P3
Canada
905 361 8910
https://microbix.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Cameron L. Groome	Pres, CEO & Director	517.44k	N/A	N/A
Mr. James S. Currie	Chief Financial Officer	253.56k	N/A	N/A
Dr. Kenneth Hughes Ph.D.	Chief Operating Officer	245.89k	N/A	N/A
Dr. Mark Luscher Ph.D.	Sr. VP of Scientific Affairs	209.26k	N/A	N/A
Mr. Philip Casselli	Sr. VP of Sales, Bus. Devel. & Marketing	233.3k	N/A	N/A
Mr. Christopher B. Lobb	Compliance Officer, Gen. Counsel & Sec.	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Corporate Governance

Microbix Biosystems Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.